BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/74/0.1/21.06.24 | Market Closed - Boerse Frankfurt Warrants 11:23:49 14/06/2024 pm IST | ||
| 1.26 EUR | -1.56% |
|
| Current month | +6.78% | ||
| 1 month | +7.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 1.26 | -1.56% |
| 13/24/13 | 1.28 | -3.03% |
| 12/24/12 | 1.32 | +5.60% |
| 11/24/11 | 1.25 | +8.70% |
| 10/24/10 | 1.15 | -10.85% |
Real-time Boerse Frankfurt Warrants
Last update June 14, 2024 at 11:23 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM575H |
| ISIN | DE000VM575H6 |
| Date issued | 30/11/2023 |
| Strike | 74 $ |
| Maturity | 21/06/2024 (6 Days) |
| Parity | 10 : 1 |
| Emission price | 0.38 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.16 € |
|---|---|
| Lowest since issue | 0.41 € |
| Spread | 0.01 € |
| Spread % | 0.79% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.29
USD
Average target price
96.24
USD
Spread / Average Target
+10.25%
- Stock Market
- Warrants
- Warrant
